Henrik Schnack

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Community Acquired Pneumonia

Coronary Artery Disease

Top Venues

ClinicoEconomics and outcomes research : CEOR

Journal of medical economics

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Nanna Nyholm, Anne Danø, Henrik Schnack, Giorgio Lorenzo Colombo
The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Nanna Nyholm, Henrik Schnack, Anne Danø, Francois Skowron
Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany. Current medical research and opinion (2023)
Jens Olsen, Henrik Schnack, Mette Skovdal, Jeffrey Vietri, Malene Buch Mikkelsen, Peter Bo Poulsen
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23. Journal of medical economics 25 (1) (2022)